International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin–exposed High-risk Non–muscle-invasive Bladder Cancer-Reference-Cited by-同舟云学术

International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin–exposed High-risk Non–muscle-invasive Bladder Cancer

Published:2021-12 Issue: Volume: Page:
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Roumiguié Mathieu,Kamat Ashish M.,Bivalacqua Trinity J.,Lerner Seth P.,Kassouf Wassim,Böhle Andreas,Brausi Maurizio,Buckley Roger,Persad Raj,Colombel Marc,Lamm Donald,Palou-Redorta Juan,Soloway Mark,Brothers Ken,Steinberg Gary,Lotan Yair,Sylvester Richard,Alfred Witjes J.,Black Peter C.

Publisher

Elsevier BV

Subject

Urology

Reference42 articles.

1. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline;Chang;J Urol,2016

2. EAU guidelines: non-muscle-invasive bladder cancer;Babjuk,2021

3. Effect of intravesical instillation of gemcitabine vs saline immediately following resection of suspected low-grade non-muscle-invasive bladder cancer on tumor recurrence: SWOG S0337 randomized clinical trial;Messing;JAMA,2018

4. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa–pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?

5. Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance;Oddens;Eur Urol,2013

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Strategies for BCG Unresponsive Non-muscle Invasive Bladder Cancer;annals of urologic oncology;2024-08-29

2. Update on the Mechanism of Action of Intravesical BCG Therapy to Treat Non-Muscle-Invasive Bladder Cancer;Frontiers in Bioscience-Landmark;2024-08-21

3. Does radical cystectomy still have a role in BCG-unresponsive nonmuscle invasive bladder cancer?;Current Opinion in Urology;2024-08-20

4. Immune-checkpoint gene expression and BCG response in non-muscle invasive bladder cancer;Translational Oncology;2024-08

5. HIVEC as an alternative option in non-muscle-invasive bladder cancer: Experiences from a high-volume center;Urologic Oncology: Seminars and Original Investigations;2024-08